Literature DB >> 28496849

Atrial Fibrillation and Heart Failure: A Review of the Intersection of Two Cardiac Epidemics.

Kay Lee Park1, Elad Anter1.   

Abstract

Atrial fibrillation and heart failure are closely linked cardiac conditions that are both increasing in prevalence due to shared risk factors and common disease mechanisms. The presence of both disease entities portends an increase in morbidity and mortality. There are significant similarities in the treatment strategies of these conditions, and the adequate management of one disease may prevent the development of the other. To this date, a rhythm control strategy, even in the heart failure population, has not been proven to be superior to a rate control strategy. This may in large be due to study design coupled with deleterious effects of antiarrhythmic agents. There have been considerable advances over the past decade in catheter and device based management of atrial fibrillation and studies aimed to examine their long-term effect in patients with heart failure are underway.

Entities:  

Keywords:  Atrial fibrillation; Epidemiology; Heart failure; Pathophysiology; Therapy

Year:  2013        PMID: 28496849      PMCID: PMC5153058          DOI: 10.4022/jafib.751

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  95 in total

1.  Gadolinium decreases stretch-induced vulnerability to atrial fibrillation.

Authors:  F Bode; A Katchman; R L Woosley; M R Franz
Journal:  Circulation       Date:  2000-05-09       Impact factor: 29.690

2.  Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.

Authors:  D Li; S Fareh; T K Leung; S Nattel
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

Review 3.  Clinical safety profile of sotalol in patients with arrhythmias.

Authors:  L F Soyka; C Wirtz; R B Spangenberg
Journal:  Am J Cardiol       Date:  1990-01-02       Impact factor: 2.778

4.  Economic impact of heart failure in the United States: time for a different approach.

Authors:  J B O'Connell; M R Bristow
Journal:  J Heart Lung Transplant       Date:  1994 Jul-Aug       Impact factor: 10.247

5.  Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function.

Authors:  Claudio Tondo; Massimo Mantica; Giovanni Russo; Andrea Avella; Lucia De Luca; Augusto Pappalardo; Rafael Lopes Fagundes; Edo Picchio; Francesco Laurenzi; Vito Piazza; Irma Bisceglia
Journal:  Pacing Clin Electrophysiol       Date:  2006-09       Impact factor: 1.976

6.  Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.

Authors:  Stavros Stavrakis; Paul Garabelli; Dwight W Reynolds
Journal:  Europace       Date:  2012-06-13       Impact factor: 5.214

7.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation.

Authors:  M Edner; K Caidahl; L Bergfeldt; B Darpö; N Edvardsson; M Rosenqvist
Journal:  Br Heart J       Date:  1995-09

8.  Rising rates of hospital admissions for atrial fibrillation.

Authors:  Jens Friberg; Pernille Buch; Henrik Scharling; Niels Gadsbphioll; Gorm B Jensen
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

9.  Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.

Authors:  I C Van Gelder; H J Crijns; P K Blanksma; M L Landsman; J L Posma; M P Van Den Berg; F L Meijler; K I Lie
Journal:  Am J Cardiol       Date:  1993-09-01       Impact factor: 2.778

10.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

View more
  11 in total

Review 1.  Anticoagulation in atrial fibrillation with heart failure.

Authors:  Lei Zhao; William Y S Wang; Xinchun Yang
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

2.  Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.

Authors:  Christopher Papandreou; Mònica Bulló; Pablo Hernández-Alonso; Miguel Ruiz-Canela; Jun Li; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Angel Alonso-Gómez; Miquel Fiol; José M Santos-Lozano; Lluís Serra-Majem; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  Clin Chem       Date:  2021-01-08       Impact factor: 8.327

3.  High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study.

Authors:  Christopher Papandreou; Pablo Hernández-Alonso; Mònica Bulló; Miguel Ruiz-Canela; Jun Li; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Montserrat Cofán; Montserrat Fitó; Cristina Razquin; Fernando Arós; Miquel Fiol; José M Santos-Lozano; Lluís Serra-Majem; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

4.  Genetic risk and atrial fibrillation in patients with heart failure.

Authors:  Mariëlle Kloosterman; Bernadet T Santema; Carolina Roselli; Christopher P Nelson; Andrea Koekemoer; Simon P R Romaine; Isabelle C Van Gelder; Carolyn S P Lam; Vicente A Artola; Chim C Lang; Leon L Ng; Marco Metra; Stefan Anker; Gerasimos Filippatos; Kenneth Dickstein; Piotr Ponikowski; Pim van der Harst; Peter van der Meer; Dirk J van Veldhuisen; Emelia J Benjamin; Adriaan A Voors; Nilesh J Samani; Michiel Rienstra
Journal:  Eur J Heart Fail       Date:  2020-01-09       Impact factor: 15.534

5.  Editorial: The Role of Calcium Handling in Heart Failure and Heart Failure Associated Arrhythmias.

Authors:  Daniel M Johnson; Alessandro Mugelli; Elisabetta Cerbai
Journal:  Front Physiol       Date:  2019-01-22       Impact factor: 4.566

Review 6.  Catheter ablation of atrial fibrillation-A key role in heart failure therapy?

Authors:  Beatriz Tose Costa Paiva; Thomas H Fischer; Johannes Brachmann; Sonia Busch
Journal:  Clin Cardiol       Date:  2019-02-12       Impact factor: 2.882

7.  Heart failure patients with atrial fibrillation benefit from remote patient management: insights from the TIM-HF2 trial.

Authors:  Tina Stegmann; Kerstin Koehler; Rolf Wachter; Volker Moeller; Samira Zeynalova; Friedrich Koehler; Ulrich Laufs
Journal:  ESC Heart Fail       Date:  2020-06-17

8.  Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF.

Authors:  Giuseppe Ambrosio; A John Camm; Jean-Pierre Bassand; Ramon Corbalan; Gloria Kayani; Erberto Carluccio; Lorenzo G Mantovani; Saverio Virdone; Ajay K Kakkar
Journal:  ESC Heart Fail       Date:  2021-01-12

9.  Healthcare utilization and cost in patients with atrial fibrillation and heart failure undergoing catheter ablation.

Authors:  Michael E Field; Michael R Gold; Motiur Rahman; Laura Goldstein; Sonia Maccioni; Abhishek Srivastava; Rahul Khanna; Jonathan P Piccini; Daniel J Friedman
Journal:  J Cardiovasc Electrophysiol       Date:  2020-10-20

10.  Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Authors:  Emmanouil Chourdakis; Ioanna Koniari; Dimitrios Velissaris; Grigorios Tsigkas; Nikolaos G Kounis; Neriman Osman
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.